Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

287 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G, Bresnihan B, Bear MB, McCabe D; European Group Of Clinical Investigators. Nuki G, et al. Among authors: mccabe d. Arthritis Rheum. 2002 Nov;46(11):2838-46. doi: 10.1002/art.10578. Arthritis Rheum. 2002. PMID: 12428223 Clinical Trial.
Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.
Camp NJ, Cox A, di Giovine FS, McCabe D, Rich W, Duff GW. Camp NJ, et al. Among authors: mccabe d. Genes Immun. 2005 Sep;6(6):467-71. doi: 10.1038/sj.gene.6364228. Genes Immun. 2005. PMID: 15931231 Clinical Trial.
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, McCabe D. Jiang Y, et al. Among authors: mccabe d. Arthritis Rheum. 2000 May;43(5):1001-9. doi: 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P. Arthritis Rheum. 2000. PMID: 10817552 Clinical Trial.
Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Bendele A, et al. Among authors: mccabe d. Arthritis Rheum. 1999 Mar;42(3):498-506. doi: 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A. Arthritis Rheum. 1999. PMID: 10088773 Clinical Trial.
Effects of interleukin-1 receptor antagonist in a slow-release hylan vehicle on rat type II collagen arthritis.
Bendele A, McAbee T, Woodward M, Scherrer J, Collins D, Frazier J, Chlipala E, McCabe D. Bendele A, et al. Among authors: mccabe d. Pharm Res. 1998 Oct;15(10):1557-61. doi: 10.1023/a:1011903100188. Pharm Res. 1998. PMID: 9794498
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P. Bresnihan B, et al. Among authors: mccabe d. Arthritis Rheum. 1998 Dec;41(12):2196-204. doi: 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2. Arthritis Rheum. 1998. PMID: 9870876 Clinical Trial.
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Cohen S, et al. Among authors: mccabe d. Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Clinical Trial.
Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.
Moreland LW, McCabe DP, Caldwell JR, Sack M, Weisman M, Henry G, Seely JE, Martin SW, Yee CL, Bendele AM, Frazier JL, Kohno T, Cosenza ME, Lyons SA, Dayer JM, Cohen AM, Edwards CK 3rd. Moreland LW, et al. Among authors: mccabe dp. J Rheumatol. 2000 Mar;27(3):601-9. J Rheumatol. 2000. PMID: 10743796 Clinical Trial.
Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin Pharmacodynamics.
Shoji S, Suzuki A, Conrado DJ, Peterson MC, Hey-Hadavi J, McCabe D, Rojo R, Tammara BK. Shoji S, et al. Among authors: mccabe d. CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):439-448. doi: 10.1002/psp4.12201. Epub 2017 May 27. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28556506 Free PMC article. Clinical Trial.
The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies.
O'Donnell JB, Ekman EF, Spalding WM, Bhadra P, McCabe D, Berger MF. O'Donnell JB, et al. Among authors: mccabe d. J Int Med Res. 2009 Nov-Dec;37(6):1789-802. doi: 10.1177/147323000903700615. J Int Med Res. 2009. PMID: 20146877 Clinical Trial.
287 results
Jump to page